MiR-134 Induces Oncogenicity And Metastasis In Head And Neck Carcinoma Through Targeting WWOX Gene.
Chung-Ji Liu, Wilma Grace Shen, Shih-Yuan Peng, Hui-Wen Cheng, S. L. Kao, Shu-Chun Lin, Kuo-Wei Chang
Published 2014 · Medicine
Download PDFAnalyze on Scholarcy
Head and neck squamous cell carcinoma (HNSCC) is a prevalent disease worldwide, and the survival of HNSCC has not improved significantly over the last few decades. MicroRNAs (miRNAs) have an important regulatory role during carcinogenesis. Our study investigated the pathogenic implications of miR-134 in head and neck carcinogenesis. The clinicopathologic implications of miR-134 in HNSCC were investigated using expression assays and the functional role of miR-134 in HNSCC pathogenesis was determined using ectopic expression, knockdown and reporter assay experiments. Xenographic tumorigenesis and orthotopic nodal metastasis were assayed in mouse models. In situ hybridization and immunohistochemistry were used to detect the expression of miR-134 and the WWOX gene in human HNSCC. The results indicated that miR-134 was upregulated in HNSCC tissues relative to control mucosa. High expression of miR-134 was associated with nodal metastasis and mortality of patients. Decreased plasma miR-134 levels after tumor ablation indicated a better prognosis for patients. Multivariate analysis showed that high miR-134 expression in HNSCC was an independent predictor of poor survival. Ectopic miR-134 expression significantly enhanced in vitro oncogenic phenotypes and the orthotopic growth and metastasis of HNSCC cells. miR-134 targeted WW domain-containing oxidoreductase (WWOX) gene and cell invasion enhanced by miR-134 expression was abrogated by ectopic WWOX expression in HNSCC cells. miR-134 expression was reversely associated with the WWOX expression in HNSCC tissues. Evidences from our study substantiated that miR-134 expression contributes to head and neck carcinogenesis by targeting the WWOX.
This paper references
Role of the WWOX tumor suppressor gene in bone C an ce r G en et ic s 820 miR-134 targets WWOX in HNSCC
S Del Mare (2014)
JNK1 Physically Interacts with WW Domain-containing Oxidoreductase (WOX1) and Inhibits WOX1-mediated Apoptosis*
N. Chang (2003)
Dramatic Co-Activation of WWOX/WOX1 with CREB and NF-κB in Delayed Loss of Small Dorsal Root Ganglion Neurons upon Sciatic Nerve Transection in Rats
Meng-Yen Li (2009)
MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance
Hsi-Feng Tu (2013)
Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue
Thian-Sze Wong (2008)
WWOX gene restoration prevents lung cancer growth in vitro and in vivo
M. Fabbri (2005)
Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
Takahiro Tsujikawa (2013)
Targeted deletion of Wwox reveals a tumor suppressor function
R. Aqeilan (2007)
Identification of Tissue-Specific MicroRNAs from Mouse
M. Lagos-Quintana (2002)
Recombinant Adeno-Associated Virus-Mediated microRNA Delivery into the Postnatal Mouse Brain Reveals a Role for miR-134 in Dendritogenesis in Vivo
Mette Christensen (2010)
Profibrotic role of miR-154 in pulmonary fibrosis.
Jadranka Milosevic (2012)
Association between High miR-211 microRNA Expression and the Poor Prognosis of Oral Carcinoma
K-W Chang (2008)
WWOX gene and gene product: tumor suppression through specific protein interactions.
Z. Salah (2010)
MiR-134 functions as a regulator of cell proliferation, apoptosis, and migration involving lung septation
Xiaoying Zhang (2012)
Hyaluronidase Induction of a WW Domain-containing Oxidoreductase That Enhances Tumor Necrosis Factor Cytotoxicity*
N. Chang (2001)
Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Linlang Guo (2010)
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function.
R. Aqeilan (2005)
WOX1 Is Essential for UVB Irradiation–Induced Apoptosis and Down-Regulated via Translational Blockade in UVB-Induced Cutaneous Squamous Cell Carcinoma In vivo
Feng-Jie Lai (2005)
WWOX, the tumour suppressor gene affected in multiple cancers.
Urszula Lewandowska (2009)
Curcumin upregulates insulin-like growth factor binding protein-5 (IGFBP-5) and C/EBPalpha during oral cancer suppression.
Kuo-Wei Chang (2010)
miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells.
Jipeng Li (2012)
Regulation of μ-opioid type 1 receptors by microRNA134 in dorsal root ganglion neurons following peripheral inflammation.
Jingshu Ni (2013)
Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells
Alexander Marson (2008)
miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma.
Chung-Ji Liu (2010)
Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells
W. Wang (2011)
Socioeconomic inequalities and oral cancer risk: a systematic review and meta-analysis of case-control studies.
D. Conway (2008)
Signaling from membrane receptors to tumor suppressor WW domain-containing oxidoreductase
Jean-Yun Chang (2010)
Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas.
F. Pimenta (2006)
Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo.
R. Aqeilan (2007)
Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer.
Vyomesh Shailesh Patel (2011)
The Tumor Suppressors p53, p63, and p73 Are Regulators of MicroRNA Processing Complex
Lakshmanane Boominathan (2010)
miR-196a Overexpression and miR-196a2 Gene Polymorphism Are Prognostic Predictors of Oral Carcinomas
Chung-Ji Liu (2012)
Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells.
K. Ried (2000)
The functions of animal microRNAs
V. Ambros (2004)
WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy.
John H Ludes-Meyers (2007)
Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer.
C-J Liu (2010)
WW domain-containing proteins: retrospectives and the future.
Z. Salah (2012)
Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma.
Sara Del Mare (2011)
MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation
Yvonne Tay (2009)
A brain-specific microRNA regulates dendritic spine development
G. Schratt (2006)
Complement C1q Activates Tumor Suppressor WWOX to Induce Apoptosis in Prostate Cancer Cells
Q. Hong (2009)
Microarray-based, high-throughput gene expression profiling of microRNAs
P. Nelson (2004)
The molecular biology of head and neck cancer
C. René Leemans (2011)
Regulation of chemotropic guidance of nerve growth cones by microRNA
L. Han (2011)
WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
A. Bednarek (2000)
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism
Junjie Xiao (2011)
Plasma microRNA biomarkers for detection of mild cognitive impairment
Kira S. Sheinerman (2012)
Role of the WWOX tumor suppressor gene in bone C an ce r G en et ic s 820 miR134 targets WWOX in HNSCC Int
GS Stein (2014)
A novel pathway regulates memory and plasticity via SIRT1 and miR-134
Jun Gao (2010)
Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
C. Liu (2008)
MicroRNAs: Target Recognition and Regulatory Functions
D. Bartel (2009)
This paper is referenced by
Recent advances in head and neck squamous cell carcinoma--a review.
Y. Safdari (2014)
Cancerous Protein Network That Inhibits the Tumor Suppressor Function of WW Domain-Containing Oxidoreductase (WWOX) by Aberrantly Expressed Molecules
Chiemi Saigo (2018)
miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.
Shih-Yuan Peng (2018)
Understanding the cancer cell phenotype beyond the limitations of current omics analyses.
Rafael Moreno-Sánchez (2016)
miR-372 inhibits p62 in head and neck squamous cell carcinoma in vitro and in vivo
Li-Yin Yeh (2015)
Clinicopathological and prognostic significance of preoperative serum epidermal growth factor levels in patients with oral squamous cell carcinoma.
J S Lin (2018)
Micro RNA as Biomarkers of Head and Neck Cancers
Giacomo Del Corso (2014)
Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations
Nalini Venkatesan (2016)
The Fra-1–miR-134–SDS22 feedback loop amplifies ERK/JNK signaling and reduces chemosensitivity in ovarian cancer cells
J. Wu (2016)
miR-3175 and miR-134 affect proliferation, invasion and apoptosis of glioma cells through PI3K/AKT signaling pathway.
Aiqin Qi (2019)
The role of WWOX polymorphisms on COPD susceptibility and pulmonary function traits in Chinese: a case-control study and family-based analysis
Chenli Xie (2016)
SMALL RIBONUCLEIC ACIDS AS POTENTIAL BIOMARKERS IN LARYNGEAL CANCER
S. Giragosyan (2019)
K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression.
Ssu-Hsueh Tseng (2015)
WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.
C Marcelo Aldaz (2014)
An integrated systems genetics screen reveals the transcriptional structure of inherited predisposition to metastatic disease.
Farhoud Faraji (2014)
The Role of MicroRNAs in Recurrence and Metastasis of Head and Neck Squamous Cell Carcinoma
Chris X Yang (2019)
Differentially expressed MicroRNAs provide mechanistic insight into fibrosis-associated liver carcinogenesis in mice.
April K. Marrone (2016)
Recurrence prediction using microRNA expression in hormone receptor positive breast cancer during tamoxifen treatment
Chungyeul Kim (2018)
MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasion.
Xiaomei Su (2017)
Role of Epigenetics in Uveal Melanoma
Yongyun Li (2017)
Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells.
Cheng-Chia Yu (2016)
MicroRNA‐134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA/VEGFR1 pathway
Long Ye Zhang (2018)
Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor
Shu-Chun Lin (2016)
Molecular Imaging and Oral Cancer Diagnosis and Therapy.
Maryam Keshavarzi (2017)
Penicillin-binding protein 1A mutation-positive Helicobacter pylori promotes epithelial-mesenchymal transition in gastric cancer via the suppression of microRNA-134
Lu Huang (2019)
miR‐134 inhibits non‐small cell lung cancer growth by targeting the epidermal growth factor receptor
Qin Qin (2016)
Impact of microRNA dynamics on cancer hallmarks: An oral cancer scenario
VG Manasa (2017)
Reduced expression of microRNA-134 correlates with malignancy and poor prognosis in human glioma
Jianfeng Zhong (2015)
Non-coding RNAs deregulation in oral squamous cell carcinoma: advances and challenges
T Yu (2015)
Differential miRNA expression profiling reveals miR-205-3p to be a potential radiosensitizer for low- dose ionizing radiation in DLD-1 cells
Rodrigo Andaur (2018)
miR-134 suppresses the migration and invasion of non‑small cell lung cancer by targeting ITGB1.
Qin Qin (2017)
Role of non-coding RNAs in head and neck squamous cell carcinoma: A narrative review.
M K Sannigrahi (2018)See more